Rolf Karlsten M.D., Ph.D.
Rolf qualified as a medical doctor at Uppsala University hospital in 1982 and continued to work at the hospital as a senior consultant in anesthesiology until 2002 when he joined AstraZeneca. At AstraZeneca he worked as medical/scientific lead within the analgesia portfolio working throughout the portfolio from discovery to the clinical development strategies. His work was primarily from early discovery to Ph IIb with several targets, several indication areas including both small and large molecules. Rolf has worked through external Key Opinion Leader networks and acted as medical responsible at agency interactions within EU and US (FDA).